Correlation Between Inozyme Pharma and Passage Bio
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Passage Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Passage Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Passage Bio, you can compare the effects of market volatilities on Inozyme Pharma and Passage Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Passage Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Passage Bio.
Diversification Opportunities for Inozyme Pharma and Passage Bio
0.69 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Inozyme and Passage is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Passage Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Passage Bio and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Passage Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Passage Bio has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Passage Bio go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Passage Bio
Given the investment horizon of 90 days Inozyme Pharma is expected to generate 0.98 times more return on investment than Passage Bio. However, Inozyme Pharma is 1.02 times less risky than Passage Bio. It trades about 0.05 of its potential returns per unit of risk. Passage Bio is currently generating about 0.0 per unit of risk. If you would invest 145.00 in Inozyme Pharma on August 28, 2024 and sell it today you would earn a total of 119.00 from holding Inozyme Pharma or generate 82.07% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Passage Bio
Performance |
| Timeline |
| Inozyme Pharma |
| Passage Bio |
Inozyme Pharma and Passage Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Passage Bio
The main advantage of trading using opposite Inozyme Pharma and Passage Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Passage Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Passage Bio will offset losses from the drop in Passage Bio's long position.| Inozyme Pharma vs. Eliem Therapeutics | Inozyme Pharma vs. HCW Biologics | Inozyme Pharma vs. Scpharmaceuticals | Inozyme Pharma vs. Milestone Pharmaceuticals |
| Passage Bio vs. Black Diamond Therapeutics | Passage Bio vs. Revolution Medicines | Passage Bio vs. Stoke Therapeutics | Passage Bio vs. Cabaletta Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |